Amit Rawat



  1. Panigrahi I, Suthar R, Rawat A, Behera B. Seizure as the presenting manifestation in Griscelli syndrome type 2. Pediatr Neurol. 2015;52:535-8 pubmed publisher
    ..Predominant neurological presentation is rare, but it represents isolated central nervous system hemophagocytosis. ..
  2. Rawat A, Bhattad S, Singh S. Chronic Granulomatous Disease. Indian J Pediatr. 2016;83:345-53 pubmed publisher
    ..However, recent evidence suggests that outcome in CGD is determined by the amount of residual NADPH oxidase activity irrespective of mode of inheritance. ..
  3. Bhattad S, Rawat A, Gupta A, Suri D, Garg R, de Boer M, et al. Early Complement Component Deficiency in a Single-Centre Cohort of Pediatric Onset Lupus. J Clin Immunol. 2015;35:777-85 pubmed publisher
    ..5 and 1.5 years respectively. Children with inherited deficiency of C1q and other early complement components present with early onset lupus that has a distinct clinical and immunological profile. ..
  4. Saikia B, Rawat A, Vignesh P. Autoantibodies and their Judicious Use in Pediatric Rheumatology Practice. Indian J Pediatr. 2016;83:53-62 pubmed publisher
    ..A restricted test ordering only in patients with clinical signs and symptoms suggestive of autoimmune disease would thus greatly increase the PPV of tests such as antinuclear antibody used for diagnosing autoimmunity. ..
  5. Vignesh P, Rawat A, Sharma M, Singh S. Complement in autoimmune diseases. Clin Chim Acta. 2017;465:123-130 pubmed publisher
  6. Singh S, Rawat A, Suri D, Gupta A, Garg R, Saikia B, et al. X-linked agammaglobulinemia: Twenty years of single-center experience from North West India. Ann Allergy Asthma Immunol. 2016;117:405-411 pubmed publisher
    ..The mean survival was 137 months (95% confidence interval, 13-163 months). The present study is perhaps the largest series of patients with XLA from any developing country so far. ..
  7. Vignesh P, Rawat A, Singh S. An Update on the Use of Immunomodulators in Primary Immunodeficiencies. Clin Rev Allergy Immunol. 2017;52:287-303 pubmed publisher
    ..This topical review explores the use of various immunomodulators and other biological agents in the context of primary immunodeficiency and autoinflammatory diseases. ..
  8. Vignesh P, Rawat A, Kumar A, Suri D, Gupta A, Lau Y, et al. Chronic Granulomatous Disease Due to Neutrophil Cytosolic Factor (NCF2) Gene Mutations in Three Unrelated Families. J Clin Immunol. 2017;37:109-112 pubmed publisher
    ..The mother of this child was a carrier for the IVS13-2A>T mutation. All three cases had colitis, and it was the initial symptom in two patients. One of the patients also developed a lung abscess due to Nocardia cyriacigeorgica. ..
  9. Hussain A, Rawat A, Jindal A, Gupta A, Singh S. Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India. Rheumatol Int. 2017;37:807-812 pubmed publisher
    ..Estimation of autoantibodies may serve as an adjunct tool in delineating and defining distinct clinical phenotypes in children diagnosed with juvenile dermatomyositis. They may also help in prognostication. ..

More Information


  1. Rawat A, Vignesh P, Sharma A, Shandilya J, Sharma M, Suri D, et al. Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India. J Clin Immunol. 2017;37:319-328 pubmed publisher
    ..The incidence of infections and mortality was significantly lower after initiation of antibacterial and antifungal prophylaxis. ..